TFF PHARMACEUTICALS, INC. Debt Conversion, Converted Instrument, Amount
TFF PHARMACEUTICALS, INC. reported Debt Conversion, Converted Instrument, Amount of $1.78 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for the quarter ending 2024-09-30 was $0.00.
- TFF PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for the quarter ending 2024-06-30 was -$13.22M.
- TFF PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for the quarter ending 2024-03-31 was $15.00M.
- TFF PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for fiscal 2023 was $15.00M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | -$13.22M derived: sum of 2 quarters · filed 2024-11-20 | $1.78M 10-Q · filed 2024-11-20 | |
| 2024-06-30 | -$13.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.78M 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | $15.00M 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | $15.00M 10-K · filed 2024-03-28 |